Literature DB >> 27097800

Local release from affinity-based polymers increases urethral concentration of the stem cell chemokine CCL7 in rats.

Edgardo Rivera-Delgado1, Zhina Sadeghi, Nick X Wang, Jonathan Kenyon, Sapna Satyanarayan, Michael Kavran, Chris Flask, Adonis Z Hijaz, Horst A von Recum.   

Abstract

The protein chemokine (C-C motif) ligand 7 (CCL7) is significantly over-expressed in urethral and vaginal tissues immediately following vaginal distention in a rat model of stress urinary incontinence. Further evidence, in this scenario and other clinical scenarios, indicates CCL7 stimulates stem cell homing for regenerative repair. This CCL7 gradient is likely absent or compromised in the natural repair process of women who continue to suffer from SUI into advanced age. We evaluated the feasibility of locally providing this missing CCL7 gradient by means of an affinity-based implantable polymer. To engineer these polymers we screened the affinity of different proteoglycans, to use them as CCL7-binding hosts. We found heparin to be the strongest binding host for CCL7 with a 0.323 nM dissociation constant. Our experimental approach indicates conjugation of heparin to a polymer backbone (using either bovine serum albumin or poly (ethylene glycol) as the base polymer) can be used as a delivery system capable of providing sustained concentrations of CCL7 in a therapeutically useful range up to a month in vitro. With this approach we are able to detect, after polymer implantation, significant increase in CCL7 in the urethral tissue directly surrounding the polymer implants with only trace amounts of human CCL7 present in the blood of the animals. Whole animal serial sectioning shows evidence of retention of locally injected human mesenchymal stem cells (hMSCs) only in animals with sustained CCL7 delivery, 2 weeks after affinity-polymers were implanted.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27097800     DOI: 10.1088/1748-6041/11/2/025022

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  6 in total

1.  Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics.

Authors:  Alan B Dogan; Katherine E Dabkowski; Horst A von Recum
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

2.  Injectable liquid polymers extend the delivery of corticosteroids for the treatment of osteoarthritis.

Authors:  Edgardo Rivera-Delgado; Ashley Djuhadi; Chaitanya Danda; Jonathan Kenyon; João Maia; Arnold I Caplan; Horst A von Recum
Journal:  J Control Release       Date:  2018-06-12       Impact factor: 9.776

3.  Affinity-Based Polymers Provide Long-Term Immunotherapeutic Drug Delivery Across Particle Size Ranges Optimal for Macrophage Targeting.

Authors:  Nathan A Rohner; Linda N Purdue; Horst A von Recum
Journal:  J Pharm Sci       Date:  2020-10-27       Impact factor: 3.534

4.  Cyclodextrin Polymer Preserves Sirolimus Activity and Local Persistence for Antifibrotic Delivery over the Time Course of Wound Healing.

Authors:  Nathan A Rohner; Steve J Schomisch; Jeffrey M Marks; Horst A von Recum
Journal:  Mol Pharm       Date:  2019-02-26       Impact factor: 5.364

5.  Affinity Effects on the Release of Non-Conventional Antifibrotics from Polymer Depots.

Authors:  Nathan A Rohner; Dung Nguyen; Horst A von Recum
Journal:  Pharmaceutics       Date:  2020-03-17       Impact factor: 6.321

6.  Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291.

Authors:  Alan B Dogan; Nathan A Rohner; Julianne N P Smith; Jessica A Kilgore; Noelle S Williams; Sanford D Markowitz; Horst A von Recum; Amar B Desai
Journal:  Pharmaceutics       Date:  2021-12-30       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.